Marine Algae as Source of Novel Antileishmanial Drugs: A Review
AbstractLeishmaniasis is a vector-borne neglected tropical disease caused by protozoan parasites of the Leishmania genus and transmitted by the female Phlebotomus and Lutzomyia sand flies. The currently prescribed therapies still rely on pentavalent antimonials, pentamidine, paromomycin, liposomal amphotericin B, and miltefosine. However, their low efficacy, long-course treatment regimen, high toxicity, adverse side effects, induction of parasite resistance and high cost require the need for better drugs given that antileishmanial vaccines may not be available in the near future. Although most drugs are still derived from terrestrial sources, the interest in marine organisms as a potential source of promising novel bioactive natural agents has increased in recent years. About 28,000 compounds of marine origin have been isolated with hundreds of new chemical entities. Recent trends in drug research from natural resources indicated the high interest of aquatic eukaryotic photosynthetic organisms, marine algae in the search for new chemical entities given their broad spectrum and high bioactivities including antileishmanial potential. This current review describes prepared extracts and compounds from marine macroalgae along with their antileishmanial activity and provides prospective insights for antileishmanial drug discovery. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Tchokouaha Yamthe, L.R.; Appiah-Opong, R.; Tsouh Fokou, P.V.; Tsabang, N.; Fekam Boyom, F.; Nyarko, A.K.; Wilson, M.D. Marine Algae as Source of Novel Antileishmanial Drugs: A Review. Mar. Drugs 2017, 15, 323.
Tchokouaha Yamthe LR, Appiah-Opong R, Tsouh Fokou PV, Tsabang N, Fekam Boyom F, Nyarko AK, Wilson MD. Marine Algae as Source of Novel Antileishmanial Drugs: A Review. Marine Drugs. 2017; 15(11):323.Chicago/Turabian Style
Tchokouaha Yamthe, Lauve R.; Appiah-Opong, Regina; Tsouh Fokou, Patrick V.; Tsabang, Nole; Fekam Boyom, Fabrice; Nyarko, Alexander K.; Wilson, Michael D. 2017. "Marine Algae as Source of Novel Antileishmanial Drugs: A Review." Mar. Drugs 15, no. 11: 323.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.